表紙:組織学・細胞学IVD市場:最新情報
市場調査レポート
商品コード
1077063

組織学・細胞学IVD市場:最新情報

Histology and Cytology IVD Market Update

出版日: | 発行: Kalorama Information | ページ情報: 英文 | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
組織学・細胞学IVD市場:最新情報
出版日: 2022年05月20日
発行: Kalorama Information
ページ情報: 英文
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要
当レポートでは、組織学・細胞学IVD市場について調査し、市場の概要とともに、組織学・細胞学の概要、検査タイプ別市場、地域別の動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場分析

  • 組織学/細胞学の概要
  • 組織学市場セグメント
  • 検査タイプ別の市場セグメント
  • 伝統的な組織の汚れ
  • PAPテスト
  • 免疫組織化学およびinsituハイブリダイゼーション
  • HPV
  • 地域別市場
  • 競争力分析
  • 組織学の商業的展望

第3章 主要な市場参加者

  • Roche Diagnostic
  • Danaher Corporation
  • Agilent
  • Illumina, Inc
  • Hologic
目次
Product Code: 22-035c

This report, “Histology and Cytology IVD Market Update ”, provides competitive analysis of the histology/cytology market from 2021 to 2026. Histology/cytology has been a mainstay of the pathological lab, providing information about cells, tissues and organs. A variety of diseases can be identified with a histopathological examination. Physicians rely on information from the pathologist as to whether there is cancer present or other disease. The physician bases their treatment and prognosis on the pathological information obtained. Technological advancements have increased the knowledge and understanding of the shape-function relationships within tissues and organs and their relationship to disease.

The industry has forged ahead with new technologies that offer increased accuracy and automated workflow. In the coming years, digital imaging, quantitative microscopy, precision microscopy, artificial intelligence and virtual histology will take the histology/cytology industry to the next level.

As discussed in the report, the histology market is a growing market with much potential. This report only looks at traditional histology. The histology report is segmented into five areas:

  • Traditional non-PAP Stains
  • PAP
  • In situ Hybridization
  • Immunohistochemistry
  • HPV

The histology report also examines and profiles five key market participants:

  • Agilent
  • Danaher
  • Hologic
  • Illumina
  • Roche

Scope and Methodology

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews, in-person interviews and email correspondence were the primary methods of gathering information. For the purpose of this study, Kalorama Information conducted interviews with industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

All market data pertains to the world market at the manufacturers' level. The market includes manufacturer tests. The base year for data was 2021. Data are provided for 2021 and 2026 with compound annual growth rates (CAGRs) for 2021 and 2026. Competitive analysis is provided for the top five participants in the market. Regional breakdowns are surveyed for United States, Europe, Asia-Pacific and Rest of World for 2021. The forecasted market analysis for 2021-2026 was largely based on demographic trends, new developments, innovative technology and global expansion.

Table of Contents

Chapter 1: Executive Summary

  • Industry at a Glance
  • Scope and Methodology
  • Size and Growth of the Market
    • Figure 1-1: Global Histology IVD Market, 2021-2026 ($millions)
  • Competitive Outlook

Chapter 2: Market Analysis

  • Overview Of Histology/Cytology
  • Histology Market Segments
    • Table 2-1: Global Histology/Cytology Sales by Type, 2021-2026 ($ millions) (Pap Tests, in situ hybridization, immunohistochemistry, traditional non-Pap stains, HPV, TOTAL)
    • Figure 2-1: Histology/Cytology Diagnostic Market Distribution by Broad Test Category, 2021
  • Market Segment by Test Type
  • Traditional Tissue Stains
    • Table 2-2: Selected Vendors of Traditional Histology Stains
  • PAP Tests
    • Table 2-3: Primary and Secondary Prevention of Cervical Cancer, Screening Responses by Country, 2019 (last updated 2020-02-12)
  • Immunohistochemistry and In-Situ Hybridization
    • Table 2-4: Selected in Situ Hybridization-based Tests
    • Table 2-5: Selected IHC Test Innovations
  • HPV
    • Figure 2-2: HPV Screening Market: HPV DNA and Pap Test Distribution of Sales, 2021
    • Table 2-6: Global HPV Molecular (DNA/RNA) Test Sales Distribution by Region, 2021 (North America, Europe, Asia Pacific, RoW)
    • Table 2-7: Selected HPV Test Innovations
  • Market by Region
    • Table 2-8: Global Histology/Cytology Sales Distribution by Region, 2021 (%) (North America, Europe, Asia Pacific, RoW)
  • Competitive Analysis
    • Table 2-9: Revenues of the Major Histology Companies, 2017-2021 ($ millions, estimated)
    • Table 2-10: 2022 Pathology Launches by Roche
  • The Commercial Outlook for Histology

Chapter 3: Major Market Participants

  • Roche Diagnostic
    • Table 3-1: Roche Diagnostic Corporate Summary
    • Figure 3-1: Roche Diagnostics Revenue by Product Group, Full Year Results 2020, 2021, CHF MN
  • Danaher Corporation
    • Table 3-2: Danaher Corporation Summary
    • Figure 3-2: Danaher Diagnostic Segment Performance, Full Year Results, 2020,2021
  • Agilent
    • Table 3-3: Agilent Corporate Summary
    • Table 3-4: Agilent Revenues 2017-2021 (millions $)
  • Illumina, Inc
    • Table 3-5: Illumina Corporate Summary
    • Table 3-6: Illumina Diagnostics Revenues 2017-2021 (millions $)
  • Hologic
    • Table 3-7: Hologic Corporate Summary
    • Figure 3-3: Hologic Diagnostic Segment Performance, Full Year Results, FY 2020, FY 2021, $M